Illumina

Onsite Service Engineer 2

California, Kentucky, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Genomic Technology, Healthcare, BiotechnologyIndustries

Requirements

Candidates should possess a BS in Electrical/Electronic Engineering, Biomedical Engineering, Mechanical Engineering, Bioengineering, or a related degree with knowledge in the biotechnology/biomedical industry, or equivalent applicable experience. A minimum of 2-4 years of relevant experience or direct experience servicing Illumina products is required, along with strong problem-solving abilities, excellent verbal and written communication skills, and the capacity to work both independently and collaboratively.

Responsibilities

The Onsite Service Engineer 2 will provide daily on-site support for the installation, upgrade, diagnosis, troubleshooting, and repair of complex Illumina equipment and systems. Responsibilities include proactively monitoring and scheduling tasks to maximize instrument uptime, managing administrative tasks like SFDC case management, building and strengthening customer relationships, performing equipment upgrades and new installations, and utilizing service manuals and bulletins. The role also involves escalating repairs as needed, running reports on instrument failures, leading meetings on instrument performance, partnering with support teams for sustaining engineering activities, and identifying opportunities for site efficiencies to decrease mean time between repair and increase instrument uptime. Additionally, the engineer will ensure proper inventory levels of service parts and act as a resource to assist other service engineers with complex issues.

Skills

Installation
Repair
Maintenance
Troubleshooting
Customer Support
Time Management
Communication
Collaboration
SFDC Case Management

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI